Contributed by: Sean Keith
The first verdict against CR Bard for their transvaginal mesh products was entered by a jury in the federal court of West Virginia on August 15, 2013. The case, which was the first case tried in the federal multi-district litigation (MDL), is a significant verdict for the thousands of cases that have been transferred to Charleston, West Virginia.
The jury returned a verdict finding that the plaintiff, a 56 year old woman who had a Bard Avaulta implant and two revisions to attempt to repair, was entitled to $250,000.00 in compensatory damages and that Bard should pay an additional 1.75 million in punitive damages to penalize the company. This is one of 8000 cases nationwide that have been filed against the Murray Hill, New Jersey based company.
The next jury trial to be tried against Bard will begin in the same West Virginia courtroom on Monday, August 19th and will be followed by yet another trial against Bard as soon as the verdict in that case is entered.
Other mesh manufacturers that have been sued for their defective products include AMS (American Medical), Boston Scientific, J&J/Ethicon and Coloplast.
If you believe you were implanted with a defective transvaginal mesh product contact our office for a free consultation.